<DOC>
	<DOCNO>NCT00144144</DOCNO>
	<brief_summary>The antihypertensive effect increase dose angiotensin II receptor blocker ( AII antagonist ) compare additional combine use amlodipine hypertensive patient Type 2 diabetes mellitus , treat AII antagonist , antihypertensive effect inadequate .</brief_summary>
	<brief_title>A Study Ca Blocker Versus AII Antagonists Hypertension With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Angiotensin Receptor Antagonists</mesh_term>
	<mesh_term>Angiotensin II</mesh_term>
	<mesh_term>Angiotensinogen</mesh_term>
	<mesh_term>Calcium Channel Blockers</mesh_term>
	<mesh_term>Angiotensin II Type 1 Receptor Blockers</mesh_term>
	<criteria>Patients type 2 diabetes mellitus . Patients treat single use AII antagonist usual least 8 week patient treat combined use AII antagonist usual dose calcium channel blocker antihypertensive drug ACE inhibitor least 8 week . Patients show systolic blood pressure ( blood pressure ) &gt; 135 mm Hg diastolic blood pressure &gt; 85 mm Hg , measure ( sit position ) outpatient basis time start observation period , show mean ( blood pressure level measure home get start study ) systolic blood pressure &gt; 130 mm Hg diastolic blood pressure &gt; 80 mm Hg measure home get last 5 day last 2week observation period . Patients whose consent obtain age 20 year . Patients whose consent obtain write form . With regard 2 ) 3 ) , however , case , mean systolic blood pressure level measure home get last 5 day first 1week observation period &gt; 180 mm Hg mean diastolic blood pressure level &gt; 110 mm Hg , include present study . Patients secondary hypertension . Patients show systolic blood pressure &gt; 180 mm Hg diastolic blood pressure &gt; 110 mm Hg measurement ( sit position ) outpatient basis time start observation period . Patients severe hepatic dysfunction . Patients severe renal dysfunction . Patients past history hypersensitiveness study drug . Pregnant , lactating , probably pregnant patient , patient want become pregnant study period . Patients participate trial within 3 month start observation period attend trial simultaneously present study . Other patient judge inappropriate subject study investigator .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2006</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Diabetes Mellitus , Type 2</keyword>
	<keyword>Calcium Channel Blocker</keyword>
	<keyword>Angiotensin II type 1 Receptor Blocker</keyword>
</DOC>